TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34646885

Group type: EXPERIMENTAL
Intervention: Immediate Implant Placement (IIP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed Implant Placement (DIP)
Number of subjects: 50
Study: 34232693

Group type: EXPERIMENTAL
Intervention: Ultrasound biofeedback
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Visual-acoustic biofeedback
Number of subjects: 7
Study: 32654884

Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resting EEG (alpha and beta power)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Event-Related Desynchronization (ERD) in theta and delta bands
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intracortical inhibition and facilitation ratios
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Event-Related Desynchronization (ERD) in delta band
Number of subjects: 36
Study: 35772133

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 29
Study: 32718746

Group type: EXPERIMENTAL
Intervention: sEMG-BFB (n = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham BFB (n = 19)
Number of subjects: 38
Study: 32799997

Group type: EXPERIMENTAL
Intervention: School-based contraceptive clinic (SBCC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Legal statutes and policies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Logistical considerations
Number of subjects: 0
Study: 35226725

Group type: EXPERIMENTAL
Intervention: Penehyclidine inhalation
Number of subjects: 864

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 864
Study: 32005206

Group type: EXPERIMENTAL
Intervention: Disabled People's Organisations (DPOs) intervention with regular home visits and financial support for public events and exposure visits to other DPOs.
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Disabled People's Organisations (DPOs) intervention.
Number of subjects: 527
Study: 35414527

Group type: EXPERIMENTAL
Intervention: Early surgery (< 12 weeks after injury)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Regular wait time (≥ 12 weeks)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 35229767

Group type: EXPERIMENTAL
Intervention: Conventional root canal therapy along with LLLT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional root canal therapy only
Number of subjects: 40
Study: 32751340

Group type: EXPERIMENTAL
Intervention: Periodontal treatment in conjunction with ozone gas therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard periodontal treatment
Number of subjects: 100
Study: 35267892

Group type: EXPERIMENTAL
Intervention: TRM30 (30% TRM replacement)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Original formula (tapioca maltodextrin)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: TRM15 (15% TRM replacement)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (original formula)
Number of subjects: 39
Study: 33054113

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (200mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Iron sucrose (200mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000 (200mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 32240016

Group type: EXPERIMENTAL
Intervention: IL (30% maximum inspiratory pressure)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CUFF (80 mmHg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: IL + CUFF
Number of subjects: 8

Group type: COMPARATOR
Intervention: CTL (no intervention)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: IL
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CUFF
Number of subjects: 8
Study: 35624525

Group type: EXPERIMENTAL
Intervention: Celery seed extract (1.34 g per day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Celery seed extract
Number of subjects: 52
Study: 33161045

Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) - 4x4‐minute sessions, 3 times weekly for 4 weeks, followed by 3 home-based sessions weekly for 48 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Moderate intensity continuous training (MICT) - 40 minutes, usual care, 3 times weekly for 4 weeks, followed by 3 home-based sessions weekly for 48 weeks
Number of subjects: 93
Study: 32720367

Group type: EXPERIMENTAL
Intervention: Fenestrated extracardiac Fontan (ECF-F), n = 20
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-fenestrated extracardiac Fontan (ECF-NF), n = 20
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fenestrated extracardiac Fontan (ECF-F)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-fenestrated extracardiac Fontan (ECF-NF)
Number of subjects: 40
Study: 34694179

Group type: COMPARATOR
Intervention: Opt-out group received Qvintip® sampling device by regular mail.
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Opt-in group received Qvintip® self-sampler by e-mail invitation.
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Opt-in group received Evalyn® Brush self-sampler by e-mail invitation.
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Self-sampling acceptance.
Number of subjects: 12000
Study: 33320764

Group type: EXPERIMENTAL
Intervention: Biocellulose with blue nanosilver dressing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Silver sulfadiazine cream
Number of subjects: 20
Study: 36382684

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at the lowest load (10 cmH2O)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 30% of maximal inspiratory pressure (MIP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 34312146

Group type: EXPERIMENTAL
Intervention: SMARTHealth India intervention managed by ASHAs
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 18
Study: 32151697

Group type: EXPERIMENTAL
Intervention: Prenotification SMS on the day of questionnaire mail-out
Number of subjects: 269

Group type: COMPARATOR
Intervention: Postnotification SMS 4 days after questionnaire mail-out
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Prenotification SMS
Number of subjects: 269

Group type: COMPARATOR
Intervention: Postnotification SMS
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Meta-analysis of two RCTs
Number of subjects: 269
Study: 36456937

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type‐A (BTX‐A)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Anterior repositioning appliance (ARA)
Number of subjects: 27
Study: 33857414

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg intravenously every 3 weeks for 1 year)
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1019
Study: 35310194

Group type: EXPERIMENTAL
Intervention: Modeling group (150 subjects)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Test group (50 subjects)
Number of subjects: 200
Study: 34108716

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine
Number of subjects: 383812

Group type: EXPERIMENTAL
Intervention: BNT162b2 (Pfizer–BioNTech) vaccine
Number of subjects: 383812

Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 383812
Study: 32787861

Group type: EXPERIMENTAL
Intervention: GigaPan®
Number of subjects: 614

Group type: COMPARATOR
Intervention: Google Street View
Number of subjects: 614
Study: 35261318

Group type: EXPERIMENTAL
Intervention: siponimod (2 mg/day)
Number of subjects: 1560

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1560
Study: 32114709

Group type: EXPERIMENTAL
Intervention: Subretinal injection of conbercept (0.5 mg/0.05 ml)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Intravitreal injection of conbercept (0.5 mg/0.05 ml)
Number of subjects: 13
Study: 33471086

Group type: EXPERIMENTAL
Intervention: HTX-011 (up to 60 mg bupivacaine/1.8 mg meloxicam) as the foundation of multimodal analgesia (MMA) regimen with ibuprofen (600 mg) and acetaminophen (1 g) every 3 hours for 72 hours.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HTX-011 with scheduled ibuprofen and acetaminophen.
Number of subjects: 31
Study: 36188178

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-Neurofeedback (sham-NF)
Number of subjects: 20
Study: 36323991

Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to Daily Occupational Performance (CO‐OP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conductive Education (CE)
Number of subjects: 12
Study: 34143285

Group type: EXPERIMENTAL
Intervention: Cardiac imaging (echocardiography, CT, MRI)
Number of subjects: 0
Study: 32436048

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 62

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 62
Study: 35710091

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) plus Compression Therapy (CT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Calf Muscle Exercise Training (CMET) plus Compression Therapy (CT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Compression Therapy (CT) alone
Number of subjects: 32
Study: 34258509

Group type: EXPERIMENTAL
Intervention: Odanacatib (anti‐cathepsin K monoclonal antibody)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Romosozumab (anti‐sclerostin monoclonal antibody)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bisphosphonates
Number of subjects: 0
Study: 35549904

Group type: EXPERIMENTAL
Intervention: Midazolam/pethidine combination
Number of subjects: 100

Group type: COMPARATOR
Intervention: Midazolam alone
Number of subjects: 100
Study: 34614745

Group type: EXPERIMENTAL
Intervention: MDI-QKD with NPRCS using different intensities of coherent states in key and test bases
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDI-QKD with NPRCS using same intensity of coherent states in key and test bases
Number of subjects: 0
Study: 33793143

Group type: EXPERIMENTAL
Intervention: Glycine (3 g twice a day for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Glucose (placebo, 3 g twice a day for 4 weeks)
Number of subjects: 20
Study: 32115159

Group type: EXPERIMENTAL
Intervention: Educational attainment
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Length of service
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Average monthly income
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Level of knowledge
Number of subjects: 243
Study: 35655483

Group type: EXPERIMENTAL
Intervention: Psychological nursing methods
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine nursing of gynecological malignant tumor chemotherapy
Number of subjects: 104
Study: 32030602

Group type: EXPERIMENTAL
Intervention: Risk score model based on predictors including age, preoperative sepsis, planned open procedure, estimated glomerular filtration rate, and preoperative albumin level.
Number of subjects: 68953
Study: 32862577

Group type: EXPERIMENTAL
Intervention: Reduced glutathione (GSH) treatment
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 96
Study: 34371524

Group type: EXPERIMENTAL
Intervention: daridorexant 50 mg single dose
Number of subjects: 24

Group type: COMPARATOR
Intervention: famotidine 40 mg single dose + daridorexant 50 mg single dose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg once a day for 10 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: daridorexant 50 mg single dose + efavirenz 600 mg once a day for 2 days
Number of subjects: 24
Study: 33852465

Group type: EXPERIMENTAL
Intervention: Micronized dermal matrix and NPWT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional NPWT
Number of subjects: 30
Study: 35582884

Group type: EXPERIMENTAL
Intervention: Educational application intervention
Number of subjects: 116

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 116
Study: 34964736

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral mirtazapine (Control)
Number of subjects: 0
Study: 35622185

Group type: EXPERIMENTAL
Intervention: MitraClip plus optimal medical therapy (OMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) alone
Number of subjects: 0
Study: 33054556

Group type: EXPERIMENTAL
Intervention: Tolcapone (a catechol-O-methyltransferase inhibitor)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 33149130

Group type: EXPERIMENTAL
Intervention: D‐Rd (daratumumab/lenalidomide/dexamethasone)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Rd (lenalidomide/dexamethasone)
Number of subjects: 569
Study: 35871013

Group type: EXPERIMENTAL
Intervention: STARKIDS intervention
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group receiving a one-time structured counselling
Number of subjects: 1000
Study: 33338896

Group type: EXPERIMENTAL
Intervention: Hybrid suture and anchor-based capsular repair
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Conventional all-suture repair
Number of subjects: 18
Study: 35543936

Group type: EXPERIMENTAL
Intervention: Scalp-nape acupuncture
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional medical symptomatic treatment + NMES and rehabilitation training (Control group)
Number of subjects: 42
Study: 35564820

Group type: EXPERIMENTAL
Intervention: Internet-based psychological intervention (I-IG)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Onsite intervention (part of I-IG)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Wait-list control group (CG)
Number of subjects: 221
Study: 33060415

Group type: EXPERIMENTAL
Intervention: Soap and water
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol swab
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Makeup removal wipe
Number of subjects: 100
Study: 32826776

Group type: EXPERIMENTAL
Intervention: Whole Health model for chronic pain care
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Local adaptations through formative evaluation
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Locally tailored pragmatic implementation strategies
Number of subjects: 74
Study: 35319299

Group type: EXPERIMENTAL
Intervention: Hypoxia (fraction in inspired oxygen: 0.10)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hyperoxia (fraction in inspired oxygen: 0.50)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 16
Study: 33316435

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (45 min, 3 times/week at 65% to 80% heart rate reserve)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 36
Study: 32335860

Group type: EXPERIMENTAL
Intervention: Tongguan Capsules (4.5 g/d) for 3 months
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard anti-platelet, anti-coagulation and lipid-decreasing treatments
Number of subjects: 400
Study: 35792926

Group type: EXPERIMENTAL
Intervention: 10-week, multimodal, bi-weekly exercise intervention (EG)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 43
Study: 32418174

Group type: EXPERIMENTAL
Intervention: Nux Vomica Capsule (NVC, 0.4 g, thrice daily) for 30 days
Number of subjects: 19
Study: 34773837

Group type: EXPERIMENTAL
Intervention: High volume hemodiafiltration (HDF)
Number of subjects: 9

Group type: COMPARATOR
Intervention: High flux hemodialysis (hf‐HD)
Number of subjects: 9
Study: 32727433

Group type: EXPERIMENTAL
Intervention: Nutritional status assessment (stunting and wasting)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Dietary diversity (mean number of food groups consumed)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Factors associated with stunting
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Factors associated with wasting
Number of subjects: 298
Study: 35717148

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB)
Number of subjects: 90

Group type: COMPARATOR
Intervention: General anaesthesia (Control)
Number of subjects: 90
Study: 32219499

Group type: EXPERIMENTAL
Intervention: Home exercise programme
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group (equal attention)
Number of subjects: 141
Study: 36243698

Group type: EXPERIMENTAL
Intervention: Spatial repellent intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33634794

Group type: EXPERIMENTAL
Intervention: Modified Atkins Diet (mAD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low Glycemic Index Treatment (LGIT)
Number of subjects: 60
Study: 35426351

Group type: EXPERIMENTAL
Intervention: Experimental exercise group (EG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control no-exercise group (CG)
Number of subjects: 0
Study: 32467089

Group type: EXPERIMENTAL
Intervention: Magnetic sphincter augmentation (MSA)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Two times a day proton pump inhibitor (PPI)
Number of subjects: 152
Study: 33125448

Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy (MST)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT) - Bitemporal (BT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT) - Right Unilateral (RUL)
Number of subjects: 60
Study: 36250434

Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation (tACS) at 10 HZ, 1 mA for 15 minutes over 10 sessions.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham stimulation (control group).
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 45
Study: 33447937

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.2 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laser therapy
Number of subjects: 0
Study: 35354411

Group type: EXPERIMENTAL
Intervention: MSB11456
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: US-licensed tocilizumab
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: EU-approved tocilizumab
Number of subjects: 685
Study: 33486982

Group type: EXPERIMENTAL
Intervention: Personalized feedback on CVD risk and discussion of risk reduction
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Active intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 40
Study: 32742206

Group type: EXPERIMENTAL
Intervention: Self Photo (SP)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Assistive Device (AD)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Other Party (OP)
Number of subjects: 88
Study: 34942508

Group type: EXPERIMENTAL
Intervention: Cultural dexterity curriculum (not specified dosage or duration)
Number of subjects: 266
Study: 33994252

Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (n=100) focusing on healthy exercise and diet
Number of subjects: 204

Group type: COMPARATOR
Intervention: Health and Wellness Intervention (n=104) with no mention of exercise or diet behavior changes
Number of subjects: 204
Study: 32879331

Group type: EXPERIMENTAL
Intervention: AI model for predicting CHD risk
Number of subjects: 1273
Study: 34813959

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (HA) coated pedicle screws
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control pedicle screws without HA (Ti6Al4V)
Number of subjects: 24
Study: 34331010

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 800 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 35818044

Group type: EXPERIMENTAL
Intervention: multimodal psychomotor program [EG1]
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: combined program (multimodal psychomotor program + whole‐body vibration program) [EG2]
Number of subjects: 51

Group type: COMPARATOR
Intervention: control group
Number of subjects: 51
Study: 33864831

Group type: EXPERIMENTAL
Intervention: Clinical systolic blood pressure (SBP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Body surface area (BSA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 24 h SBP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Daily SBP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nightly SBP
Number of subjects: 100
Study: 32631305

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 12

Group type: COMPARATOR
Intervention: PSV1
Number of subjects: 12

Group type: COMPARATOR
Intervention: PSV2
Number of subjects: 12
Study: 37064289

Group type: EXPERIMENTAL
Intervention: Online Yoga Intervention (OYI)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Yoga cum Ayurveda Intervention (OYAI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 72
Study: 33249081

Group type: EXPERIMENTAL
Intervention: Scrambler Therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 50
Study: 33785226

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Misoprostol/Diclofenac
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control (no pharmacologic treatment)
Number of subjects: 247
Study: 35320165

Group type: EXPERIMENTAL
Intervention: Hands parallel to trunk (Group C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hands above head (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hands behind head (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hands on chest (Group D)
Number of subjects: 60
Study: 33000120

Group type: EXPERIMENTAL
Intervention: Adaboost model (machine learning algorithm)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Knosp grade and postoperative immediate morning serum cortisol (PoC)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Preoperative 24-hour urine free cortisol, PoC, and age
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Machine learning models (general)
Number of subjects: 201
Study: 33319443

Group type: EXPERIMENTAL
Intervention: Mamma Mia
Number of subjects: 1950

Group type: EXPERIMENTAL
Intervention: Mamma Mia Plus
Number of subjects: 1950

Group type: COMPARATOR
Intervention: Usual prenatal/postpartum care
Number of subjects: 1950